Friday, March 25, 2016 2:14:03 PM
2 hours 19 minutes ago - DJNF
BioTelemetry, Inc. Signs Definitive Agreement to Acquire VirtualScopics, Inc.
MALVERN, Pa. and ROCHESTER, N.Y., March 25, 2016 (GLOBE NEWSWIRE) -- BioTelemetry, Inc. (NASDAQ:BEAT), the leading wireless medical technology company focused on the delivery of health information to improve quality of life and reduce cost of care, and VirtualScopics, Inc. (NASDAQ:VSCP), a leading provider of clinical trial imaging solutions, announced today that the two companies have entered into a definitive agreement whereby BioTelemetry will acquire VirtualScopics.
BioTelemetry will commence an all cash tender offer for all outstanding common and preferred shares of VirtualScopics. In the tender offer, BioTelemetry will offer investors $4.05 per share for VirtualScopics' common stock, $336.30 per share for VirtualScopics' Series A and Series B Convertible Preferred Stock and $920.00 per share for VirtualScopics' Series C-1 Convertible Preferred Stock. The total purchase consideration is approximately $15.5 million.
The tender offer is expected to commence on or about April 11, 2016, and will be open for a minimum of 20 business days. VirtualScopics' Board has approved the transaction and has agreed to unanimously recommend to its stockholders that they tender their shares of VirtualScopics' common and preferred stock in the tender offer. Stockholders holding approximately 20% of VirtualScopics' current outstanding voting stock have agreed, among other things, to tender their voting stock pursuant to the tender offer.
The closing of the transaction is conditioned on the tender and acceptance of at least a majority of the outstanding voting stock and a majority of the Series C-1 Convertible Preferred Stock as well as other customary conditions. BioTelemetry will acquire any VirtualScopics' shares not purchased in the tender offer in a second-step merger at the same per-share price paid in the tender offer. The closing of the transaction is expected to occur in the second quarter of 2016.
VirtualScopics today reports revenue of $12.7 million for 2015. The Company expects to release its full 2015 financial results in its annual report on Form 10-K later today.
Joseph H. Capper, President and Chief Executive Officer of BioTelemetry, commented: "We are excited to further expand our clinical research offerings with the addition of VirtualScopics' imaging capabilities. This acquisition demonstrates our continued commitment to growing our clinical research business. VirtualScopics possesses an excellent scientific and operational reputation and we look forward to building upon their longstanding relationships with their customers. We would like to welcome VirtualScopics' employees and customers to the BioTelemetry family and we look forward to the successful completion of the merger."
VirtualScopics' Chief Executive Officer, Eric Converse, added: "We believe BioTelemetry is the perfect partner for the future of VirtualScopics. They possess the scale and resources to accelerate our growth plan and lead the company into the future. This is an exciting time for everyone at VirtualScopics and we look forward to joining the BioTelemetry team."
Greenberg Traurig, LLP acted as legal counsel to BioTelemetry. Oppenheimer & Co. acted as exclusive financial advisor and Woods Oviatt Gilman LLP acted as legal counsel to VirtualScopics.
DUKE BASKETBALL and NOTRE DAME FOOTBALL
Recent BEAT News
- HeartBeam to Host First Quarter 2023 Results Conference Call on Thursday May 9, 2024 at 4:30 p.m. Eastern Time • Business Wire • 04/25/2024 12:31:00 PM
- HeartBeam Presents Positive Results on its Artificial Intelligence Capabilities for Detecting Arrhythmias • Business Wire • 04/09/2024 12:31:00 PM
- HeartBeam Reports Fourth Quarter and Full Year 2023 Financial Results • Business Wire • 03/20/2024 08:05:00 PM
- First Patients Enrolled in Pivotal Study Evaluating HeartBeam’s AIMIGo™ System for Synthesizing a 12-Lead ECG • Business Wire • 03/14/2024 12:31:00 PM
- HeartBeam Receives Two New US Patents for its Core Cardiac Monitoring Technology • Business Wire • 03/07/2024 01:31:00 PM
- HeartBeam to Host Fourth Quarter and Full Year 2023 Results Conference Call on Wednesday March 20, 2024 at 4:30 p.m. Eastern Time • Business Wire • 03/05/2024 01:31:00 PM
- HeartBeam Unveils AI Program Designed to Deliver Unprecedented Personalized Cardiac Insights • Business Wire • 12/14/2023 01:31:00 PM
- HeartBeam Reports Third Quarter 2023 Financial Results • Business Wire • 11/14/2023 09:01:00 PM
- HeartBeam Announces Expansion of Its Scientific Advisory Board • Business Wire • 11/09/2023 01:31:00 PM
- HeartBeam Granted Third US Patent for 12-Lead Extended Wear Patch for Detecting Heart Attacks and Complex Cardiac Arrythmias • Business Wire • 11/07/2023 01:31:00 PM
- HeartBeam to Host Third Quarter 2023 Results Conference Call on Tuesday November 14, 2023 at 4:30 p.m. Eastern Time • Business Wire • 10/31/2023 12:31:00 PM
- Implicity Expands Senior Leadership Team with New U.S. Chief Commercial Officer • PR Newswire (US) • 09/27/2023 12:05:00 PM
- HeartBeam Appoints Richa Gujarati and Pooja Chatterjee to Senior Management Team • Business Wire • 09/26/2023 12:31:00 PM
- Dawson James Securities Announces October Date for 8th Annual Small Cap Growth Conference • GlobeNewswire Inc. • 09/21/2023 01:35:00 PM
- HeartBeam Reports Second Quarter 2023 Financial Results • Business Wire • 08/10/2023 08:01:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/10/2023 08:00:36 PM
- HeartBeam Announces Publication of Foundational Study on the Detection of Heart Attacks • Business Wire • 08/09/2023 12:31:00 PM
- HeartBeam Appoints Deborah Castillo as Vice President of Regulatory Affairs • Business Wire • 08/08/2023 12:31:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/05/2023 01:43:51 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/05/2023 01:41:10 AM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 08/02/2023 10:39:25 PM
- HeartBeam to Host Second Quarter 2023 Results Conference Call on Thursday August 10, 2023 at 4:30 p.m. Eastern Time • Business Wire • 07/27/2023 12:31:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/26/2023 12:35:33 PM
Bantec Reports an Over 50 Percent Increase in Sales and Profits in Q1 2024 from Q1 2023 • BANT • Apr 25, 2024 10:00 AM
Cannabix's Breath Logix Alcohol Device Delivers Positive Impact to Private Monitoring Agency in Montana, USA • BLO • Apr 25, 2024 8:52 AM
Kona Gold Beverages, Inc. Announces Name Change to NuVibe, Inc. and Initiation of Ticker Symbol Application Process • KGKG • Apr 25, 2024 8:30 AM
Axis Technologies Group and Carbonis Forge Ahead with New Digital Carbon Credit Technology • AXTG • Apr 24, 2024 3:00 AM
North Bay Resources Announces Successful Equipment Test at Bishop Gold Mill, Inyo County, California • NBRI • Apr 23, 2024 9:41 AM
Epazz, Inc.: CryObo, Inc. solar Bitcoin operations will issue tokens • EPAZ • Apr 23, 2024 9:20 AM